期刊
EUROPEAN JOURNAL OF INORGANIC CHEMISTRY
卷 -, 期 23, 页码 3879-3891出版社
WILEY-V C H VERLAG GMBH
DOI: 10.1002/ejic.201500602
关键词
Antitumor agents; Medicinal chemistry; Peptides; Photoactivated chemotherapy; Ruthenium
资金
- Swiss National Science Foundation [PP00P2_133568, PP00P2_157545]
- University of Zurich
- Stiftung fur Wissenschaftliche Forschung of the University of Zurich
- Novartis Jubilee Foundation
- Stiftung zur Krebsbekampfung
- Huggenberger-Bischoff Stiftung
- University of Zurich Priority Program
Photoactivated chemotherapy (PACT) relies on the use of a drug and light to cause cell death. Unlike photodynamic therapy (PDT), its mechanism of action is independent of the presence of oxygen in tissues. This approach is therefore also effective for tumours characterized by hypoxic conditions. Herein we present the use of three novel Ru-II-polypyridyl complexes derivatized with a light-sensitive cage and targeting peptides as selective PACT agents. Light irradiation allowed the selective release of the cytotoxic compounds from the molecular cages in living cells. Further selectivity was conferred on the system by a peptide carrier (i.e., bombesin), which targets receptors overexpressed on the membranes of HeLa cells. As expected, this peptide was found to provide an increased uptake of the systems in HeLa cells compared with normal MRC-5 cells. As a result, for two of the compounds presented in this study, no cyto- or phototoxicity was observed in MRC-5 cells, whereas in HeLa cells, upon light irradiation, IC50 values of 42.2 and 60.0 M were obtained, which correspond to a two-fold increase in toxicity.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据